A detailed history of Essex Investment Management CO LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 58,385 shares of ITCI stock, worth $4.48 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
58,385
Previous 31,448 85.66%
Holding current value
$4.48 Million
Previous $2.15 Million 98.28%
% of portfolio
0.8%
Previous 0.43%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$67.99 - $80.84 $1.83 Million - $2.18 Million
26,937 Added 85.66%
58,385 $4.27 Million
Q2 2024

Aug 12, 2024

BUY
$64.76 - $79.84 $1.96 Million - $2.41 Million
30,215 Added 2450.53%
31,448 $2.15 Million
Q1 2024

May 03, 2024

SELL
$64.37 - $75.65 $31,927 - $37,522
-496 Reduced 28.69%
1,233 $85,000
Q4 2023

Feb 07, 2024

SELL
$46.37 - $73.65 $17,620 - $27,987
-380 Reduced 18.02%
1,729 $123,000
Q3 2023

Nov 09, 2023

SELL
$52.09 - $64.1 $1,041 - $1,282
-20 Reduced 0.94%
2,109 $109,000
Q1 2023

May 04, 2023

SELL
$43.8 - $56.99 $1,138 - $1,481
-26 Reduced 1.21%
2,129 $115,000
Q4 2022

Feb 02, 2023

BUY
$44.07 - $54.45 $94,970 - $117,339
2,155 New
2,155 $114,000
Q4 2018

Feb 06, 2019

SELL
$10.36 - $20.96 $345,858 - $699,728
-33,384 Closed
0 $0
Q3 2018

Oct 16, 2018

BUY
$17.77 - $22.9 $24,593 - $31,693
1,384 Added 4.32%
33,384 $724,000
Q2 2018

Jul 17, 2018

BUY
$17.33 - $23.4 $78,972 - $106,633
4,557 Added 16.61%
32,000 $565,000
Q1 2018

Apr 26, 2018

BUY
$15.16 - $25.49 $416,035 - $699,522
27,443 New
27,443 $578,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.25B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.